Growth Hormone or HGH how it is commonly known, is one of the most important regulatory hormones produced in the human body. Produced in the anterior pituitary gland via stimulation from Growth Hormone Releasing Hormone, which is produced in the Hypothalamus, HGH plays a mayor role in multiple metabolic processes including carbohydrate, fat and protein metabolism as well as indirect effect on the growth of cartilage, muscle and bone via its stimulation on the liver to produce IGF-1 which stimulates amino acid uptake and protein synthesis in muscle and other tissues like bone and cartilage leading to subsequent tissue growth. Additionally, HGH has been known to have effect on the Central Nervous System and skin.
What is Adult Growth Hormone Deficiency (AGHD)
Like most hormones naturally produced in the human body, HGH production begins to decline during early adulthood. Although there are well known external factors that can influence HGH levels such as poor sleep, stress, poor diet and lack of exercise or physical activity, it is understood that most adults will produce 50% less HGH by their mid 30’s and early 40’s leading to:
Early identification of this decline and initiation of treatment is recommended to reduce the physical and physiological signs of aging that accompany Growth Hormone deficiency.
The cost of treatment for AGHD used to be prohibitive due to the high cost of recombinant Growth Hormone. Today, the cost of treatment is only about 10% of what it was in the early 2000’s due to the development of other treatment option like Growth Hormone Releasing Hormone (GHRH) and Growth Hormone Releasing Peptide (GHRP).
Growth Hormone Releasing Hormone (GHRH) like the name suggest, acts directly on the pituitary gland to signal release and increase circulating HGH levels with studies showing a 2-10 fold increase. However, due to its site of action, HGH levels are still susceptible due the effects of regulatory hormones like Somatostatin which can have direct effect on GH secretion.
The addition of Growth Hormone Releasing Peptide (GHRP) can counter this effect increasing the release of Ghrelin which is not only a potent stimulator for GH release but also inhibits somatostatin release.
Unlike treatment with HGH, therapy with GHRH and GHRP does not cause supra-physiologic levels of circulating Growth Hormone and IGF-1 levels requiring less frequent monitoring and having a decreased risk of adverse side effects.
Please contact us directly at (210) 892-2118 with any questions, comments, or scheduling inquiries you may have and get started today on your Hormone Replacement Therapy.
Feel free to fax any documents to (210) 892-1211
10103 West Loop 1604N Suite 105, San Antonio, Texas 78254